Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murone, M.
Right arrow Articles by de Sauvage, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murone, M.
Right arrow Articles by de Sauvage, F. J.
Stem Cells, Vol. 16, No. 1, 1-6, January 1998
© 1998 AlphaMed Press

Concise Review

Hematopoietic Deficiencies in c-mpl and TPO Knockout Mice

Maximilien Murone, David A. Carpenter, Frederic J. de Sauvage

The Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, USA

Key Words. Thrombopoietin • c-mpl • Platelets • Stem cells • Thrombocytopenia • Hematopoiesis

Dr. Frederic J. de Sauvage, Genentech, Inc., One DNA Way, South San Francisco, CA 94080, USA.

Thrombopoietin (TPO) is the primary regulator of megakaryocyte (Meg) and platelet production. Its receptor, c-mpl, is a member of the cytokine receptor superfamily. Major insight into the physiological role of this receptor/ligand pair came from the study of mice carrying disrupted alleles of these two genes. Both TPO and c-mpl knockout mice are viable, but have a 90% reduction in platelet counts. Their thrombocytopenia is caused by a reduction in progenitor cell numbers and a decrease in Meg ploidy. However, the Megs and platelets produced in the absence of TPO or c-mpl appear morphologically and functionally normal indicating that, in vivo, the main role of TPO is to control their numbers, rather than their maturation. In addition to its effect on the Meg lineage, TPO also affects hematopoietic stem cells as measured by a reduction of the repopulating capacity of bone marrow cells from c-mpl-deficient mice. Finally, analysis of these gene targeted mice provided substantial evidence to a model where the circulating TPO level is directly regulated by the platelet mass through binding to c-mpl receptors present at the platelet surface. This elegant feedback mechanism allows a tight regulation of the amount of TPO available to stimulate megakaryocytopoiesis.




This article has been cited by other articles:


Home page
 BloodHome page
S. Jeanpierre, F. E. Nicolini, B. Kaniewski, C. Dumontet, R. Rimokh, A. Puisieux, and V. Maguer-Satta
BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling
Blood, October 15, 2008; 112(8): 3154 - 3163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Dordelmann, R. Telgmann, E. Brand, C. Hagedorn, B. Schroer, S. Hasenkamp, P. Baumgart, P. Kleine-Katthofer, M. Paul, and S.-M. Brand-Herrmann
Functional and Structural Profiling of the Human Thrombopoietin Gene Promoter
J. Biol. Chem., September 5, 2008; 283(36): 24382 - 24391.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Sebastian, M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada
Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells
J. Immunol., May 1, 2008; 180(9): 5898 - 5906.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. H. Zhang, S. Basu, F. Wu, C. G. Begley, C. J. M. Saris, A. R. Dunn, A. W. Burgess, and F. Walker
Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF
J. Leukoc. Biol., October 1, 2007; 82(4): 915 - 925.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H.-G. Kopp, S. T. Avecilla, A. T. Hooper, S. V. Shmelkov, C. A. Ramos, F. Zhang, and S. Rafii
Tie2 activation contributes to hemangiogenic regeneration after myelosuppression
Blood, July 15, 2005; 106(2): 505 - 513.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. D. Dahlen, V. C. Broudy, and J. G. Drachman
Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs
Blood, July 1, 2003; 102(1): 102 - 108.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
I. M. P. Joseph, Y. Zavros, J. L. Merchant, and D. Kirschner
A model for integrative study of human gastric acid secretion
J Appl Physiol, April 1, 2003; 94(4): 1602 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. J. Blake, B. J. Jenkins, R. J. D'Andrea, and T. J. Gonda
Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the {beta}-subunit of the GM-CSF receptor
J. Leukoc. Biol., December 1, 2002; 72(6): 1246 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
E.-M. Wolber and W. Jelkmann
Thrombopoietin: The Novel Hepatic Hormone
Physiology, February 1, 2002; 17(1): 6 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
J.-H. Kie, W.-I. Yang, M.-K. Lee, T.-J. Kwon, Y.-H. Min, H.-O. Kim, H.-S. Ahn, S.-A. Im, H.-L. Kim, H.-Y. Park, et al.
Decrease in Apoptosis and Increase in Polyploidization of Megakaryocytes by Stem Cell Factor During Ex Vivo Expansion of Human Cord Blood CD34+ Cells Using Thrombopoietin
Stem Cells, January 1, 2002; 20(1): 73 - 79.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
G. D. Demetri
Targeted Approaches for the Treatment of Thrombocytopenia
Oncologist, October 1, 2001; 6(2008): 15 - 23.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
B. D. Car and V. M. Eng
Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice
Vet. Pathol., January 1, 2001; 38(1): 20 - 30.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. J. Lane, S. Dias, K. Hattori, B. Heissig, M. Choy, S. Y. Rabbany, J. Wood, M. A. S. Moore, and S. Rafii
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases
Blood, December 15, 2000; 96(13): 4152 - 4159.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. A. Harker, L. K. Roskos, U. M. Marzec, R. A. Carter, J. K. Cherry, B. Sundell, E. N. Cheung, D. Terry, and W. Sheridan
Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers
Blood, April 15, 2000; 95(8): 2514 - 2522.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C.-C. Shih, M. C.-T. Hu, J. Hu, Y. Weng, P. J. Yazaki, J. Medeiros, and S. J. Forman
A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells
Blood, March 15, 2000; 95(6): 1957 - 1966.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Yagi, K. A. Ritchie, E. Sitnicka, C. Storey, G. J. Roth, and S. Bartelmez
Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
PNAS, July 6, 1999; 96(14): 8126 - 8131.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1998 by AlphaMed Press.